Literature DB >> 25243322

Lower values of VEGF in endometrial secretion are a possible cause of subfertility in non-atopic asthmatic patients.

Elisabeth Juul Gade1, Simon Francis Thomsen, Svend Lindenberg, Nick S Macklon, Vibeke Backer.   

Abstract

OBJECTIVE: Using endometrial secretion analysis, we assessed whether altered inflammatory cytokine levels can be detected in the uterine environment in asthma patients, thereby providing a possible cause of reduced fertility in asthmatics.
METHODS: Forty-four unexplained infertile women (aged 28-44) underwent asthma and allergy testing, questionnaires, endometrial secretion and blood samples in the mid-secretory phase of the menstrual cycle (day 19-23) during assisted reproduction. Differences in cytokines and growth factors were analyzed.
RESULTS: Mean log-VEGF in uteri was lower in asthma patients compared with controls (2.29 versus 2.70, p = 0.028). This was mainly due to lower values of VEGF among women with non-atopic asthma compared with women with atopic asthma (1.86 versus 2.72, p = 0.009) and with healthy controls (1.86 versus 2.70, p = 0.01). Asthma treatment status had no effect on VEGF levels in uteri. Serum high sensitivity CRP was negatively correlated with VEGF in endometrial secretions. No other significant correlations were observed between peripheral blood values and markers found in utero.
CONCLUSION: Asthma is associated with lower values of VEGF in uterine endometrial secretions, which might affect the receptiveness of the endometrium and thereby increase time to pregnancy. The effect appears to be associated with non-atopic asthma with general increased systemic inflammation.

Entities:  

Keywords:  Asthma; VEGF; endometrial secretion samples; infertility; systemic inflammation

Mesh:

Substances:

Year:  2014        PMID: 25243322     DOI: 10.3109/02770903.2014.966915

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  4 in total

1.  Female asthma and atopy - impact on fertility: a systematic review.

Authors:  Joan Bláfoss; Anne Vejen Hansen; Sara S Malchau Lauesgaard; Zarqa Ali; Charlotte Suppli Ulrik
Journal:  J Asthma Allergy       Date:  2019-07-24

2.  Treatment with the anti-IgE monoclonal antibody omalizumab in women with asthma undergoing fertility treatment: a proof-of-concept study-The PRO-ART study protocol.

Authors:  Casper Tidemandsen; Elisabeth Juul Gade; Charlotte Suppli Ulrik; Henriette Svarre Nielsen; Birgitte Sophie Oxlund-Mariegaard; Karsten Kristiansen; Nina La Cour Freiesleben; Bugge Nøhr; Hanne Udengaard; Vibeke Backer
Journal:  BMJ Open       Date:  2020-11-12       Impact factor: 2.692

3.  May mepolizumab used in asthma correct subfertility?

Authors:  Guzin Ozden; Pelin Pınar Deniz
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

4.  Curcumol Ameliorates Lung Inflammation and Airway Remodeling via Inhibiting the Abnormal Activation of the Wnt/β-Catenin Pathway in Chronic Asthmatic Mice.

Authors:  Shanshan Jia; Pin Guo; Junhua Lu; Xujun Huang; Laming Deng; Yan Jin; Lanyan Zhao; Xiaofang Fan
Journal:  Drug Des Devel Ther       Date:  2021-06-21       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.